Author

Sarah Rippke

Institution: University of Colorado Denver

Observed institution: University of Colorado Denver

OpenAlex ID: A5015060405

Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal Cancer

2018 · Anuradha Krishnamurthy, Arvind Dasari, et al. · Cancer Research · 29

A phase IB study of the combination of selumetinib (AZD6244, ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).

2017 · Anuradha Krishnamurthy, A. Dasari, et al. · Journal of Clinical Oncology · 2

A phase IB study of the combination of selumetinib (AZD6244; ARRY-142886) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC).

2017 · Anuradha Krishnamurthy, A. Dasari, et al. · Journal of Clinical Oncology · 2

Abstract CT146: A phase IB study of the combination of AZD6244 hydrogen sulfate (selumetinib) and cyclosporin A (CsA) in patients with advanced solid tumors with an expansion cohort in metastatic colorectal cancer (mCRC)

2016 · Anna Capasso, Arvind Dasari, et al. · Cancer Research

Works count: 4

Citation count: 33

H-index: 2

I10-index: 1